Clinical Trials for Elpen Pharmaceutical

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Elpen Pharmaceutical

Clinical Trials (5)

Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

N/ANot yet recruiting

140 participants

Started: Jun 1, 2025 · Completed: Dec 31, 2027

1 condition2 sponsors0 locations

Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

450 participants

Started: Oct 23, 2024 · Completed: Sep 30, 2025

1 condition1 sponsor6 locations

QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt.

N/ANot yet recruiting

500 participants

Started: Mar 31, 2024 · Completed: Feb 28, 2026

1 condition1 sponsor0 locations

TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.

210 participants

Started: Mar 6, 2024 · Completed: Dec 31, 2025

1 condition1 sponsor1 location

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

300 participants

Started: Jan 1, 2022 · Completed: Jun 1, 2024

5 conditions1 sponsor1 location